Amprius Technologies, Inc. 8-K

What Happened

• Amprius Technologies, Inc. (AMPX) announced on Jan 12, 2026 that it successfully completed all sales under its at-the-market equity offering program established under the At Market Issuance Sales Agreement dated October 2, 2023.
• Under that Sales Agreement (with B. Riley Securities, Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC as sales agents), the company issued an aggregate 25.5 million shares of common stock, producing aggregate net proceeds of approximately $97.5 million.
• During the three months ended December 31, 2025, Amprius sold shares that generated about $19.6 million in net proceeds at an average price of $11.17 per share. The Sales Agreement terminated following the sale of all shares available and the company does not intend further sales under that agreement.

Key Details

• Sales Agreement date: October 2, 2023; Sales Agents: B. Riley, Cantor Fitzgerald, H.C. Wainwright.
• Authorized offering size under the agreement: up to $100.0 million.
• Shares issued under the program: 25.5 million common shares.
• Aggregate net proceeds to Amprius: ~ $97.5 million; proceeds in the quarter ended Dec 31, 2025: ~ $19.6 million (avg price $11.17/share).

Why It Matters

• The company has completed a major equity financing channel it had in place, securing roughly $97.5M in net capital that can be used for operations, R&D, manufacturing scale-up, or other corporate needs.
• Completion of the ATM means Amprius has ended this particular source of incremental share issuances—investors now know the program under the October 2023 Sales Agreement is closed and no further sales will be made under it.
• The issuance increased the company's outstanding share count (25.5M new shares), which is important to consider when assessing dilution and per-share metrics going forward.